Literature DB >> 2802805

Pulse methylprednisolone therapy in rheumatoid arthritis.

M D Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2802805      PMCID： PMC1003878          DOI： 10.1136/ard.48.9.789-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood.

Authors:  M D Smith; M J Ahern; P M Brooks; P J Roberts-Thomson
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study.

Authors:  C J Needs; M Smith; J Boutagy; S Donovan; D Cosh; M McCredie; P M Brooks
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects.

Authors:  M D Smith; J V Bertouch; A M Smith; M Weatherall; M J Ahern; P M Brooks; P J Roberts-Thomson
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

4.  Pulse steroid therapy and the search for improved drug therapy of rheumatoid arthritis.

Authors:  R J Sebaldt
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

5.  Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

Authors:  M D Smith; M J Ahern; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

6.  Pulse steroid therapy, rheumatoid arthritis and the Journal of Rheumatology.

Authors:  A Kraus
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

7.  Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis.

Authors:  M Radia; D E Furst
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

8.  Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.

Authors:  M T Walters; M I Cawley
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

Authors:  I A Williams; A D Mitchell; W Rothman; P Tallett; K Williams; P Pitt
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.